Publicaciones (24) Publicaciones en las que ha participado algún/a investigador/a

2006

  1. A new technique for biotechnological products loading into microparticles

    Minerva Biotecnologica, Vol. 18, Núm. 1, pp. 39-49

  2. Atazanavir.

    Revista de medicina, Vol. 50, Núm. 1, pp. 41-45

  3. Bioadhesive mannosylated nanoparticles for oral drug delivery

    Journal of Nanoscience and Nanotechnology

  4. Biodegradable micro- and nanoparticles as long-term delivery vehicles for gentamicin

    Journal of Microencapsulation, Vol. 23, Núm. 7, pp. 782-792

  5. Biofilm related infections: Is there a place for conservative treatment of port-related bloodstream infections?

    International Journal of Artificial Organs, Vol. 29, Núm. 4, pp. 379-386

  6. Brucella outer membrane complex-loaded microparticles as a vaccine against Brucella ovis in rams

    Vaccine, Vol. 24, Núm. 11, pp. 1897-1905

  7. Chemical and biological factors in the control of Brucella and brucellosis

    Current Drug Delivery, Vol. 3, Núm. 4, pp. 359-365

  8. Comparing antimicrobial and membrane permeabilizing activity of peptides derived from human cationic proteins

    UNDERSTANDING BIOLOGY USING PEPTIDES

  9. Determination of gentamicin in different matrices by a new sensitive high-performance liquid chromatography-mass spectrometric method

    Journal of Antimicrobial Chemotherapy, Vol. 58, Núm. 3, pp. 557-563

  10. Development of a novel vaccine delivery system based on gantrez nanoparticles

    Journal of Nanoscience and Nanotechnology

  11. Encapsulation of antigenic extracts of Salmonella enterica serovar. Abortusovis into polymeric systems and efficacy as vaccines in mice

    Veterinary Microbiology, Vol. 118, Núm. 1-2, pp. 124-132

  12. Enterovirus 75 and aseptic meningitis, Spain, 2005 [6]

    Emerging Infectious Diseases

  13. Experiments on a sub-unit vaccine encapsulated in microparticles and its efficacy against Brucella melitensis in mice

    Vaccine, Vol. 24, Núm. 19, pp. 4179-4187

  14. Increases of efficacy as vaccine against Brucella abortus infection in mice by simultaneous inoculation with avirulent smooth bvrS/bvrR and rough wbkA mutants

    Vaccine, Vol. 24, Núm. 15, pp. 2910-2916

  15. Infecciones más comunes en el paciente trasplantado

    Anales del sistema sanitario de Navarra, Vol. 29, Núm. 2, pp. 175-205

  16. Influence of N-acylation of a peptide derived from human lactoferricin on membrane selectivity

    Biochimica et Biophysica Acta - Biomembranes, Vol. 1758, Núm. 9, pp. 1426-1435

  17. Influenza outbreaks in highly-vaccinated older institutionalised people in the 2004-2005 season [2]

    Medicina Clinica, Vol. 126, Núm. 1, pp. 35-36

  18. Intracellular killing of Brucella melitensis in human macrophages with microsphere-encapsulated gentamicin

    Journal of Antimicrobial Chemotherapy, Vol. 58, Núm. 3, pp. 549-556

  19. Multiplex PCR assay for the identification and differentiation of all Brucella species and the vaccine strains Brucella abortus S19 and RB51 and Brucella melitensis Rev1 [13]

    Clinical Chemistry

  20. Nanocarriers with gentamicin to treat intracellular pathogens

    Journal of Nanoscience and Nanotechnology